Outset Medical: Revenue Trajectory Yet To Reflect Favorable Demand Tailwinds [Seeking Alpha]
Outset Medical, Inc. (OM)
Company Research
Source: Seeking Alpha
Q2 gross margin was 38.4%, impacted by temporary headwinds, and should gradually expand towards management's mid-term target of 50%. I expect cash burn this year of $45 million, with break-even likely reached in 2028, supported by gross profit growth significantly outpacing operating expense growth. Though execution risk is high, OM's stock trades at an undemanding valuation, especially compared to relevant peers. I am maintaining a hold rating on the stock. Frank Brennan/iStock via Getty Images Outset Medical ( NASDAQ: OM ) represents a compelling growth story where its Tablo product has a massive addressable market for acute and post-acute dialysis. This market is estimated at $2.5 billion, where current penetration is only This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it
Show less
Read more
Impact Snapshot
Event Time:
OM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OM alerts
High impacting Outset Medical, Inc. news events
Weekly update
A roundup of the hottest topics
OM
News
- INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Outset Medical, Inc. (NASDAQ: OM) and Encourages Investors with Substantial Losses to Contact the FirmPR Newswire
- Outset Medical (NASDAQ:OM) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Outset Medical (NASDAQ:OM) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=OM&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</MarketBeat
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OMPR Newswire
- Outset Medical (OM): Assessing Valuation After Q3 Miss, Sales Leadership Exit, and Steep Stock Drop [Yahoo! Finance]Yahoo! Finance
OM
Earnings
- 11/10/25 - Beat
OM
Sec Filings
- 12/2/25 - Form 4
- 11/18/25 - Form 4
- 11/18/25 - Form 4
- OM's page on the SEC website